PW Medtech Group Limited (HKG:1358)
Hong Kong · Delayed Price · Currency is HKD 1.190
+0.010 (0.85%)
May 12, 2026, 3:59 PM HKT
PW Medtech Group Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 94.37 | 150.78 | 153.18 | 106.04 | 739.12 |
Depreciation & Amortization | 139.84 | 117.73 | 98.24 | 78.58 | 31.41 |
Other Amortization | 0.02 | 0.02 | 0.02 | 0.01 | 0 |
Loss (Gain) From Sale of Assets | 0.07 | 0.11 | 7.14 | 0.01 | -731.79 |
Asset Writedown & Restructuring Costs | 1.82 | 1.18 | 0.06 | 11.65 | 52.59 |
Loss (Gain) From Sale of Investments | -5.95 | -0.37 | - | - | - |
Stock-Based Compensation | 26.45 | 18.6 | - | - | - |
Provision & Write-off of Bad Debts | -6.5 | -2.67 | -4.17 | -2.72 | 1.14 |
Other Operating Activities | -11.17 | -14.11 | -23.24 | 57.2 | -66.98 |
Change in Accounts Receivable | 16.25 | -1.59 | -11.49 | -28.46 | 3.71 |
Change in Inventory | -27.33 | 15.24 | -4.57 | -5.46 | 5.86 |
Change in Accounts Payable | 15.78 | 7.4 | 5.65 | 40.42 | 2.82 |
Change in Unearned Revenue | 9.83 | 10.58 | -5.09 | 7.26 | -0.64 |
Change in Other Net Operating Assets | -12.78 | 15.54 | - | - | - |
Operating Cash Flow | 240.7 | 318.43 | 211.03 | 269.23 | 37.24 |
Operating Cash Flow Growth | -24.41% | 50.89% | -21.62% | 622.91% | -52.38% |
Capital Expenditures | -90.05 | -56.5 | -47.31 | -52.46 | -11.32 |
Sale of Property, Plant & Equipment | 2.62 | 0.55 | 3.7 | 0.11 | 0.14 |
Cash Acquisitions | - | - | - | -1,014 | - |
Divestitures | - | - | 35.99 | - | - |
Sale (Purchase) of Intangibles | -15.01 | -15.58 | -34.61 | -9.4 | - |
Sale (Purchase) of Real Estate | - | 0.82 | - | - | - |
Investment in Securities | 4.37 | -0.25 | 0.73 | 48.83 | 2,770 |
Other Investing Activities | 44.78 | 50.65 | 43.83 | 35.37 | 57.34 |
Investing Cash Flow | 6.71 | -20.32 | -26.67 | -1,082 | 2,636 |
Long-Term Debt Issued | 9.2 | 5.8 | - | - | - |
Total Debt Issued | 9.2 | 5.8 | - | - | - |
Long-Term Debt Repaid | -2.13 | -1.5 | -0.67 | -83.64 | -28.42 |
Total Debt Repaid | -2.13 | -1.5 | -0.67 | -83.64 | -28.42 |
Net Debt Issued (Repaid) | 7.07 | 4.3 | -0.67 | -83.64 | -28.42 |
Repurchase of Common Stock | -19.76 | -80.22 | - | -3.06 | - |
Common Dividends Paid | -130.35 | -134.37 | -71.6 | - | -2,062 |
Other Financing Activities | 16.53 | -0.37 | 89.8 | 1.54 | -0.6 |
Financing Cash Flow | -126.51 | -210.66 | 17.53 | -85.16 | -2,091 |
Foreign Exchange Rate Adjustments | -0.05 | 4.89 | 5.84 | -4.6 | 0.63 |
Net Cash Flow | 120.86 | 92.33 | 207.74 | -902.86 | 582.99 |
Free Cash Flow | 150.66 | 261.93 | 163.73 | 216.77 | 25.92 |
Free Cash Flow Growth | -42.48% | 59.98% | -24.47% | 736.25% | -63.14% |
Free Cash Flow Margin | 18.30% | 34.06% | 24.25% | 40.38% | 9.55% |
Free Cash Flow Per Share | 0.10 | 0.17 | 0.10 | 0.14 | 0.02 |
Cash Interest Paid | 0.72 | 0.37 | 0.15 | 0.46 | 0.6 |
Cash Income Tax Paid | 41.25 | 36.97 | 44.56 | 14.33 | 7.01 |
Levered Free Cash Flow | 16.94 | 229.72 | 233.51 | -236.55 | 2,229 |
Unlevered Free Cash Flow | 17.39 | 229.95 | 233.6 | -236.26 | 2,229 |
Change in Working Capital | 1.75 | 47.17 | -15.5 | 13.76 | 11.74 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.